MONTREAL, QUEBEC--(Marketwire - March 26, 2008) - Thallion Pharmaceuticals Inc. (TSX: TLN) today announced that the redemption date of all outstanding special preferred shares of the share capital of the Company was March 25, 2008. As of that date, the special preferred shares - which were issued to former Caprion shareholders as a means to potentially participate in a subsequent sale of certain assets related to Caprion - were automatically redeemed as per the terms and conditions of those special preferred shares. Final proceeds totaling $1.00 has been set aside for redemption of the special preferred shares in relation to this event and all other rights of these special preferred shares have been automatically terminated.
